T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TE
1351
DELISTED
TECO ENERGY INC
TE
| $8.74M | ﹤0.01% |
426,785
+59,620
| +16% | +$1.15M |
|
1352
Assurant
AIZ
$13.9B
| $8.71M | ﹤0.01% |
127,260
+3,900
| +3% | +$260K |
|
1353
Howard Hughes
HHH
$4.04B
| $8.69M | ﹤0.01% |
69,890
-4,301
| -6% | -$575K |
|
1354
Insulet
PODD
$10.2B
| $8.65M | ﹤0.01% |
187,881
+167,760
| +834% | +$7.18M |
|
1355
Boise Cascade
BCC
$2.94B
| $8.65M | ﹤0.01% |
232,750
-22,275
| -9% | -$767K |
|
1356
Terex
TEX
$7.57B
| $8.55M | ﹤0.01% |
306,748
-4,349,111
| -93% | -$124M |
|
|
TYPE
1357
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $8.51M | ﹤0.01% |
295,289
+10,869
| +4% | +$305K |
|
1358
Dr. Reddy's Laboratories
RDY
$10.3B
| $8.4M | ﹤0.01% |
832,895
-96,515
| -10% | -$1.02M |
|
1359
Toll Brothers
TOL
$14B
| $8.32M | ﹤0.01% |
242,910
+14,290
| +6% | +$466K |
|
1360
LivePerson
LPSN
$35.9M
| $8.3M | ﹤0.01% |
39,237
-9,852
| -20% | -$2.02M |
|
1361
Pitney Bowes
PBI
$2.28B
| $8.25M | ﹤0.01% |
338,381
+100
| +0% | +$2.44K |
|
1362
Avery Dennison
AVY
$13.6B
| $8.22M | ﹤0.01% |
158,516
-2,400
| -1% | -$114K |
|
|
HCBK
1363
DELISTED
HUDSON CITY BANCORP INC
HCBK
| $8.19M | ﹤0.01% |
809,689
-14,200
| -2% | -$137K |
|
1364
Designer Brands
DBI
$312M
| $8.16M | ﹤0.01% |
218,862
-4,200
| -2% | -$137K |
|
1365
Revvity
RVTY
$13.1B
| $8.15M | ﹤0.01% |
186,409
+5,500
| +3% | +$237K |
|
1366
Berkshire Hathaway Class A
BRK.A
$1.09T
| $8.14M | ﹤0.01% |
36
| – | – |
|
1367
Ascent Industries
ACNT
$134M
| $8.13M | ﹤0.01% |
461,671
-103,359
| -18% | -$1.71M |
|
1368
CorVel
CRVL
$3.25B
| $8.12M | ﹤0.01% |
654,798
+13,500
| +2% | +$155K |
|
|
CPLA
1369
DELISTED
Capella Education Company
CPLA
| $8.12M | ﹤0.01% |
+105,537
| New | +$7.26M |
|
1370
Grupo Cibest SA
CIB
$22.7B
| $8.12M | ﹤0.01% |
169,600
+36,500
| +27% | +$1.94M |
|
|
PBCT
1371
DELISTED
People's United Financial Inc
PBCT
| $8.1M | ﹤0.01% |
533,447
+20
| +0% | +$293 |
|
|
CTRX
1372
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $8.06M | ﹤0.01% |
155,832
+3,294
| +2% | +$155K |
|
|
MDVN
1373
DELISTED
MEDIVATION, INC.
MDVN
| $8.06M | ﹤0.01% |
161,934
-13,136
| -8% | -$683K |
|
|
SRT
1374
DELISTED
Startek Inc.
SRT
| $8.04M | ﹤0.01% |
824,730
+200
| +0% | +$1.66K |
|
|
PAY
1375
DELISTED
Verifone Systems Inc
PAY
| $7.97M | ﹤0.01% |
214,352
+870
| +0.4% | +$30.6K |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.